The Journal of Clinical Hypertension (Jan 2023)

Sustained cannabis use does not predispose clinical hypertension: Findings from a national survey

  • Rohan M. Shah,
  • Shiv Patel,
  • Sareena Shah,
  • Sahil Doshi,
  • Angela Li,
  • Joseph A. Diamond

DOI
https://doi.org/10.1111/jch.14623
Journal volume & issue
Vol. 25, no. 1
pp. 47 – 52

Abstract

Read online

Abstract Cannabis is among the most used recreational and medicinal drugs in the United States. The effects of chronic use on hypertension remain poorly understood. Our study retrospectively evaluated data collected by the National Health and Nutrition Examination Survey from 2017 to 2018. Cannabis use was measured with five metrics: (1) sustained use at any point in the past, (2) sustained use within the past year, (3) frequency of use, (4) age of first cannabis use, and (5) current use. Hypertension status was determined by individuals reporting having been diagnosed in the past. Multivariable logistic regressions were performed, controlling for age, race, and gender. A total of 4565 respondents were identified, of which 867 (19.0%) reported sustained cannabis use in the past. Participants who reported past sustained cannabis use did not have statistically different odds of having hypertension (OR: 1.12; 95% CI: .66–1.91; p = .6). Moderate (OR: 1.08; 95% CI: .36–3.25; p = .8) and highly‐frequent users (OR: 1.30; 95% CI: .56–3.03; p = .4) did not have different odds of having hypertension than infrequent users. No relationship between the age of first cannabis use and hypertension was observed. The recency of sustained cannabis use was not associated with hypertension status. Current cannabis users had similar odds of hypertension as past users (OR: 1.03; 95% CI: .59–1.79; p = .9). The findings of this study indicate that neither past nor current cannabis use is associated with clinical hypertension.

Keywords